Annual CFF
-$842.92 M
+$653.87 M+43.68%
31 December 2023
Summary:
BioNTech SE annual cash flow from financing activities is currently -$842.92 million, with the most recent change of +$653.87 million (+43.68%) on 31 December 2023. During the last 3 years, it has fallen by -$1.86 billion (-182.50%). BNTX annual CFF is now -182.50% below its all-time high of $1.02 billion, reached on 31 December 2020.BNTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$9.40 M
+$15.19 M+61.78%
01 September 2024
Summary:
BioNTech SE quarterly cash flow from financing activities is currently -$9.40 million, with the most recent change of +$15.19 million (+61.78%) on 01 September 2024. Over the past year, it has increased by +$328.47 million (+97.22%). BNTX quarterly CFF is now -101.26% below its all-time high of $747.05 million, reached on 30 September 2020.BNTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$51.69 M
+$328.47 M+86.40%
01 September 2024
Summary:
BioNTech SE TTM cash flow from financing activities is currently -$51.69 million, with the most recent change of +$328.47 million (+86.40%) on 01 September 2024. Over the past year, it has increased by +$914.19 million (+94.65%). BNTX TTM CFF is now -104.89% below its all-time high of $1.06 billion, reached on 30 September 2020.BNTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.7% | +97.2% | +94.7% |
| 3 y3 years | -182.5% | +7.2% | -118.4% |
| 5 y5 years | -295.5% | -103.4% | -118.3% |
BNTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -182.5% | +43.7% | -110.4% | +98.9% | -118.4% | +97.3% |
| 5 y | 5 years | -182.5% | +43.7% | -101.3% | +98.9% | -104.9% | +97.3% |
| alltime | all time | -182.5% | +43.7% | -101.3% | +98.9% | -104.9% | +97.3% |
BioNTech SE Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.40 M(-61.8%) | -$51.69 M(-86.4%) |
| June 2024 | - | -$24.58 M(+190.2%) | -$380.15 M(-29.4%) |
| Mar 2024 | - | -$8.47 M(-8.3%) | -$538.52 M(-36.1%) |
| Dec 2023 | -$842.92 M(-43.7%) | -$9.24 M(-97.3%) | -$842.92 M(-12.7%) |
| Sept 2023 | - | -$337.86 M(+84.7%) | -$965.88 M(-22.5%) |
| June 2023 | - | -$182.95 M(-41.5%) | -$1.25 B(-34.4%) |
| Mar 2023 | - | -$312.87 M(+136.7%) | -$1.90 B(+26.9%) |
| Dec 2022 | -$1.50 B(-1442.9%) | -$132.20 M(-78.6%) | -$1.50 B(+5.3%) |
| Sept 2022 | - | -$617.69 M(-26.2%) | -$1.42 B(+74.6%) |
| June 2022 | - | -$837.00 M(-1028.9%) | -$814.29 M(-493.4%) |
| Mar 2022 | - | $90.11 M(-257.3%) | $206.98 M(+85.7%) |
| Dec 2021 | $111.46 M | -$57.27 M(+465.6%) | $111.46 M(-60.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$10.13 M(-105.5%) | $280.23 M(-73.0%) |
| June 2021 | - | $184.27 M(-3498.2%) | $1.04 B(+2.3%) |
| Mar 2021 | - | -$5.42 M(-104.9%) | $1.01 B(-0.7%) |
| Dec 2020 | $1.02 B(+138.1%) | $111.51 M(-85.1%) | $1.02 B(-3.4%) |
| Sept 2020 | - | $747.05 M(+364.0%) | $1.06 B(+80.2%) |
| June 2020 | - | $161.01 M(+7195.0%) | $586.79 M(+36.4%) |
| Mar 2020 | - | $2.21 M(-98.5%) | $430.22 M(+0.3%) |
| Dec 2019 | $429.10 M(-0.5%) | $146.98 M(-46.9%) | $429.10 M(+52.1%) |
| Sept 2019 | - | $276.59 M(+6134.4%) | $282.12 M(+5005.3%) |
| June 2019 | - | $4.44 M(+307.3%) | $5.53 M(+407.3%) |
| Mar 2019 | - | $1.09 M | $1.09 M |
| Dec 2018 | $431.20 M(<-9900.0%) | - | - |
| Dec 2017 | -$1.86 M | - | - |
FAQ
- What is BioNTech SE annual cash flow from financing activities?
- What is the all time high annual CFF for BioNTech SE?
- What is BioNTech SE annual CFF year-on-year change?
- What is BioNTech SE quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for BioNTech SE?
- What is BioNTech SE quarterly CFF year-on-year change?
- What is BioNTech SE TTM cash flow from financing activities?
- What is the all time high TTM CFF for BioNTech SE?
- What is BioNTech SE TTM CFF year-on-year change?
What is BioNTech SE annual cash flow from financing activities?
The current annual CFF of BNTX is -$842.92 M
What is the all time high annual CFF for BioNTech SE?
BioNTech SE all-time high annual cash flow from financing activities is $1.02 B
What is BioNTech SE annual CFF year-on-year change?
Over the past year, BNTX annual cash flow from financing activities has changed by +$653.87 M (+43.68%)
What is BioNTech SE quarterly cash flow from financing activities?
The current quarterly CFF of BNTX is -$9.40 M
What is the all time high quarterly CFF for BioNTech SE?
BioNTech SE all-time high quarterly cash flow from financing activities is $747.05 M
What is BioNTech SE quarterly CFF year-on-year change?
Over the past year, BNTX quarterly cash flow from financing activities has changed by +$328.47 M (+97.22%)
What is BioNTech SE TTM cash flow from financing activities?
The current TTM CFF of BNTX is -$51.69 M
What is the all time high TTM CFF for BioNTech SE?
BioNTech SE all-time high TTM cash flow from financing activities is $1.06 B
What is BioNTech SE TTM CFF year-on-year change?
Over the past year, BNTX TTM cash flow from financing activities has changed by +$914.19 M (+94.65%)